Vocimagene amiretrorepvec
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Vocimagene amiretrorepvec
- DrugBank Accession Number
- DB15331
- Background
Vocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)).
- Type
- Biotech
- Groups
- Investigational
- Synonyms
- Vocimagene amiretrorepvec
- External IDs
- TOCA 511
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- DC4WO3WA4Q
- CAS number
- 1300724-82-6
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2, 3 Terminated Treatment Anaplastic Astrocytoma (AA) / Glioblastoma Multiforme (GBM) 1 2, 3 Withdrawn Treatment Anaplastic Astrocytoma (AA) / High Grade Glioma: Glioblastoma (GBM) / Oligodendroglioma / Supratentorial Glioblastoma 1 1 Completed Treatment Anaplastic Astrocytoma (AA) / Anaplastic Oligo-astrocytoma (AOA) / Anaplastic Oligodendroglioma (AO) / Glioblastoma Multiforme (GBM) 2 1 Completed Treatment Anaplastic Astrocytoma (AA) / Anaplastic Oligo-astrocytoma (AOA) / Anaplastic Oligodendroglioma (AO) / High Grade Glioma: Glioblastoma (GBM) 1 1 Terminated Treatment Astrocytoma / Glioblastoma Multiforme (GBM) / Malignant Glioma 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at May 20, 2019 15:15 / Updated at February 21, 2021 18:55